To evaluate the concordance of ChatGPT-4's therapeutic recommendations for brain tumor cases with those of human experts and established guidelines in neuro-oncology radiotherapy, using specific metrics for assessment.
Key Findings:
ChatGPT-4's recommendations showed varying levels of concordance with expert decisions across different case complexities, with specific percentages to illustrate these levels.
Performance was highest in low-complexity cases and decreased in intermediate and high-complexity cases.
Discrepancies were noted, particularly in high-complexity cases where clinical judgment is crucial.
Interpretation:
ChatGPT-4 demonstrates potential as a clinical decision support tool, but its reliability decreases in complex cases requiring nuanced clinical judgment, which may impact patient outcomes.
Limitations:
The study was conducted at a single institution, limiting generalizability and introducing potential biases.
ChatGPT-4 may lack up-to-date clinical knowledge and could produce hallucinated information.
The AI's performance may vary based on the complexity of cases and tumor types.
Conclusion:
While ChatGPT-4 can assist in radiotherapy decision-making, further validation and integration into clinical workflows are necessary, especially for complex cases, with specific recommendations for future research.
